TIANQING GROUP
Tianqing Group is a comprehensive group which engages in real estate, education and logistics projects.
TIANQING GROUP
Social Links:
Founded:
2000-01-31
Status:
Active
Contact:
86-931-8526320
Email Addresses:
[email protected]
Technology used in webpage:
Domain Not Resolving Euro Pound Sterling Japanese Yen China Ministry Of Public Security
Similar Organizations
Similan Group
Similan Group is a comprehensive investment group which engages in different kinds of investment projects.
Tonker Holdings
Tonker Holdings is a comprehensive company which mainly engages in real estate development and investment projects.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2015-06-03 | E Zhanggui | Tianqing Group investment in Angel Round - E Zhanggui | 10 M CNY |
More informations about "Tianqing Group"
Team - QuinzeCent
TIANQING INVESTMENT GROUP is the Canadian subsidiary of Gansu Tianqing Group Real Estate Co. Ltd. Established in 2000, Gansu Tianqing now has projects in cities across China, in the U.S. and in Canada. It has received …See details»
Équipe | QuinzeCent
Groupe Tianqing Investment est la filiale canadienne de la Gansu Tianqing Group Real Estate Co. Ltd. Gansu Tianqing compte maintenant plusieurs complexes immobiliers en Chine, de même …See details»
Tianqing Group - Investments, Portfolio & Company Exits
Tianqing Group has invested in E Zhanggui on Jun 3, 2015. This investment - Angel Round - E Zhanggui - was valued at . obfuscated. obfuscated. How many investments has this …See details»
GROUPE BRIVIA ET GROUPE TIANQING …
Mar 21, 2019 Tianqing Investment Group est la filiale canadienne de Gansu Tianqing Group Real Estate Co. Ltd, la plus importante société immobilière de la province de Gansu en Chine. Fondée en 2000, la société a connu 18 ans …See details»
LE GROUPE BRIVIA ET LE GROUPE TIANQING ANNONCENT LE …
Sep 24, 2018 Tianqing Investment Group est la filiale canadienne de Gansu Tianqing Group Real Estate Co. Ltd, la plus importante société immobilière de la province de Gansu en Chine. …See details»
Brivia Group and Tianqing Group start construction of the
Mar 21, 2019 About Tianqing Investment Group Tianqing Investment Group is the Canadian subsidiary of Gansu Tianqing Group Real Estate Co. Ltd., ... Organization Profile. Brivia Group.See details»
BRIVIA GROUP AND TIANQING GROUP START …
Montréal, March 21, 2019 – Mr. Kheng Ly, President and Chief Executive Officer of Brivia Group, Montréal’s fast-growing property developer and investor, and the Tianqing Group today held a ground-breaking ceremony marking the start of …See details»
Tianqing Group - Tech Stack, Apps, Patents & Trademarks
Tianqing Group is a comprehensive group which engages in real estate, education and logistics projects. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. …See details»
Quinzecent | Platinum VIP Pricing & Plans - condotrend.com
TianQing Group. Tianqing Group, founded in 2000, is the biggest real estate business in China's Gansu province, with approximately 36 million square feet of development space and 5,100 …See details»
Quinzecent Condos in Montreal by Brivia Group and TianQing Group
Quinzecent, a visionary condo community developed by Brivia Group and TianQing Group, is situated at 1500 Boulevard René-Lévesque Ouest, Montréal. Completed in 2023, this …See details»
TQB2922 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 21, 2024 TQB2922, Now, its global highest R&D status is Phase 1, Therapeutic Areas: Neoplasms, Active Indication: Advanced cancer, Active Org.: Chia Tai Tianqing …See details»
TQB-3912 - Drug Targets, Indications, Patents - Synapse - Patsnap
Dec 12, 2024 TQB-3912, Initially developed by Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Now, its global highest R&D status is Phase 1, Therapeutic Areas: Neoplasms,Skin and …See details»
tianqing group - Brivia Group
Montreal, September 24, 2018 – The Brivia Group, a fast-growing Montreal real-estate developer and investor, and the Tianqing Group are delighted to announce today a... Read More …See details»
TQG3020 - Drug Targets, Indications, Patents - Synapse
Nov 21, 2024 TQG3020, Initially developed by Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Now, its global highest R&D status is IND Approval, Therapeutic Areas: Cardiovascular …See details»
BRIVIA GROUP AND TIANQING GROUP ANNOUNCE THE …
Montreal, September 24, 2018 – The Brivia Group, a fast-growing Montreal real-estate developer and investor, and the Tianqing Group are delighted to announce today a brand new …See details»
TQB2029 - Drug Targets, Indications, Patents - Synapse
TQB2029: a CD3 inhibitors, GPRC5D inhibitors Drug, Initially developed by Nanjing Shunxin Pharmaceutical Co., Ltd., Now, its global highest R&D status is Phase 1, Mechanism: CD3 …See details»
China sanctions 20 in Canada, two groups who advocate for …
5 days ago China has imposed sanctions against two Canadian organizations and their members who advocate for ethnic groups repressed by Beijing. Targets include Canada’s …See details»
TQB-3455 - Drug Targets, Indications, Patents - Synapse - Patsnap
Dec 12, 2024 To evaluate the safety and tolerability of oral TQB3455 tablets in Chinese subjects with advanced malignant tumors, and their pharmacokinetic characteristics; to determine the …See details»
Unecritinib - Drug Targets, Indications, Patents - Synapse - Patsnap
Jun 30, 2023 Background: TQ-B3101 is a novel kinase inhibitor currently in development for the treatment of advanced malignant solid tumor and relapsed or refractory ALK-positive …See details»
TQ-B3234 - Drug Targets, Indications, Patents - Synapse
Nov 21, 2024 This study is a Phase I clinical trial to evaluate the tolerability and pharmacokinetics of TQ-B3234 capsules in Chinese subjects associated with …See details»